Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention
RecruitingNCT07630597Phase: NAStarted 2026-05-08
Summary
This single-center, randomized, single-blind, sham-controlled pilot study aims to evaluate the adjunctive effect of transcutaneous auricular vagus nerve stimulation (taVNS) in overweight/obese patient
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
50 Years
Locations
Department of Endocrinology, the Affiliated Drum Tower HospiNanjing, Jiangsu, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07630597